ادوکسابان (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "ادوکسابان" in Persian language version.

refsWebsite

Global rank Persian rank

4^th place

5^th place

68^th place

179^th place

3web.archive.org

1^st place

1^st place

2^nd place

2^nd place

447^th place

382^nd place

399^th place

104^th place

1daiichi-sankyo.eu

low place

low place

719^th place

248^th place

102^nd place

515^th place

daiichi-sankyo.eu

"First market approval in Japan for Lixiana (Edoxaban)". Daiichi Sankyo Europe GmbH (Press release). 22 April 2011. Archived from the original on 6 November 2013.

doi.org

Parasrampuria DA, Truitt KE (June 2016). "Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting FactorXa". Clinical Pharmacokinetics. 55 (6): 641–55. doi:10.1007/s40262-015-0342-7. PMC 4875962. PMID 26620048.
Lowenstern A, Al-Khatib SM, Sharan L, Chatterjee R, Allen LaPointe NM, Shah B, et al. (December 2018). "Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review". Annals of Internal Medicine. 169 (11): 774–787. doi:10.7326/M18-1523. PMC 6825839. PMID 30383133.

drugs.com

"Edoxaban (Savaysa) Use During Pregnancy". Drugs.com. 17 June 2020. Retrieved 25 September 2020.

europa.eu

ema.europa.eu

"Lixiana EPAR". آژانس دارویی اروپا (EMA). Retrieved 23 July 2020.
"Roteas EPAR". آژانس دارویی اروپا (EMA). Retrieved 25 September 2020.
"Lixiana, INN-edoxaban" (PDF). Archived (PDF) from the original on 6 November 2019. Retrieved 6 November 2019.
"Ondexxya". European Medicines Agency. 27 February 2019. Archived from the original on 16 July 2019. Retrieved 6 November 2019.

fda.gov

accessdata.fda.gov

"Drug Approval Package: Savaysa (edoxaban tosylate) Tablets NDA #206316". U.S. سازمان غذا و دارو (آمریکا) (FDA). 13 February 2015. Retrieved 23 July 2020.

fda.gov

Ovanesov, Mikhail (3 August 2017). "Summary basis for regulatory action - ANDEXXA". سازمان غذا و دارو (آمریکا). Retrieved 6 November 2019.

handle.net

hdl.handle.net

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

medscape.com

O'Riordan, Michael (9 January 2015). "FDA Approves Edoxaban for Stroke Prevention in AF and DVT/PE Prevention". Medscape. Retrieved 10 January 2015.

nih.gov

ncbi.nlm.nih.gov

Parasrampuria DA, Truitt KE (June 2016). "Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting FactorXa". Clinical Pharmacokinetics. 55 (6): 641–55. doi:10.1007/s40262-015-0342-7. PMC 4875962. PMID 26620048.
Lowenstern A, Al-Khatib SM, Sharan L, Chatterjee R, Allen LaPointe NM, Shah B, et al. (December 2018). "Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review". Annals of Internal Medicine. 169 (11): 774–787. doi:10.7326/M18-1523. PMC 6825839. PMID 30383133.

pubmed.ncbi.nlm.nih.gov

Parasrampuria DA, Truitt KE (June 2016). "Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting FactorXa". Clinical Pharmacokinetics. 55 (6): 641–55. doi:10.1007/s40262-015-0342-7. PMC 4875962. PMID 26620048.
Lowenstern A, Al-Khatib SM, Sharan L, Chatterjee R, Allen LaPointe NM, Shah B, et al. (December 2018). "Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review". Annals of Internal Medicine. 169 (11): 774–787. doi:10.7326/M18-1523. PMC 6825839. PMID 30383133.

dailymed.nlm.nih.gov

"Savaysa- edoxaban tosylate tablet, film coated". DailyMed. 24 April 2020. Retrieved 23 July 2020.

web.archive.org

"First market approval in Japan for Lixiana (Edoxaban)". Daiichi Sankyo Europe GmbH (Press release). 22 April 2011. Archived from the original on 6 November 2013.
"Lixiana, INN-edoxaban" (PDF). Archived (PDF) from the original on 6 November 2019. Retrieved 6 November 2019.
"Ondexxya". European Medicines Agency. 27 February 2019. Archived from the original on 16 July 2019. Retrieved 6 November 2019.